The therapeutic potential of synthetic human atrial natriuretic peptide in nephrotic syndrome: a randomized controlled trial

@inproceedings{Kanzaki2012TheTP,
  title={The therapeutic potential of synthetic human atrial natriuretic peptide in nephrotic syndrome: a randomized controlled trial},
  author={Motoko Kanzaki and Jun Wada and Yoko Kikumoto and Shigeru Akagi and Kazushi Nakao and Hitoshi Sugiyama and Hirofumi Makino},
  booktitle={International journal of nephrology and renovascular disease},
  year={2012}
}
BACKGROUND In nephrotic syndrome, the combination of furosemide and albumin infusion is a standard regimen to treat systemic edema. The efficacy of synthetic human atrial natriuretic peptide (hANP) for nephrotic syndrome to ameliorate the systemic edema and retain renal functions has not been fully demonstrated. TRIAL DESIGN We conducted a prospective… CONTINUE READING